Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: March 2007
-
By Christopher P. Singer — The USPTO published a pre-OG notice regarding its new position on restriction practice in pending applications that relate to nucleic acid sequences. Prior to this notice, the PTO had been officially operating under the direction of an Official Gazette notice dated November 19, 1996. The old notice allowed…
-
By Donald Zuhn — Schering-Plough Corporation announced on March 12th that its Board of Directors has approved the purchase of Organon BioSciences N.V. from Akzo Nobel N.V. for US $14.4 billion. Schering-Plough chairman and CEO Fred Hassan noted that the acquisition would give Schering-Plough immediate access to central nervous system and women’s health…
-
By Jason Derry — MacroArray Technologies, LLC has announced that it has licensed its PCADM-1 antibody test to Abbott. The PCADM-1 protein is a prostate specific protein that can be detected in the urine. The protein is overexpressed in malignant prostate tumors. Under the terms of the agreement, Abbott will develop and market…
-
By Sherri Oslick About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Cypress Pharmaceutical, Inc. v. Tiber Laboratories, LLC 3:07-cv-00108; filed February 20, 2007 in the Southern District of Mississipi Declaratory judgment of noninfringement and…
-
March 21-22, 2007 – Complex IP & Technology Transactions Conference (Law Seminars International) – Chicago, IL March 25-29, 2007 – American Chemical Society National Meeting – Chicago, IL April 16-18, 2007 – Biotechnology: Patent Prosecution, Licensing, Litigation & Hatch-Waxman (Patent Resources Group) – Orlando, FL April 27, 2007 – Patent Claim Construction Workshop (Law Seminars…
-
By Donald Zuhn On March 9, 2007, Innogenetics announced that the Federal Circuit reinstated a permanent injunction issued by the District Court for the Western District of Wisconsin against Abbott Laboratories. In September 2005, Innogenetics sued Abbott Laboratories for infringement of U.S. Patent No. 5,846,704, which covers a method of genotyping hepatitis C…
-
Court Finds That HDI’s Glucometer Does Not Infringe Roche Patent By Robert Dailey A District Court in Indianapolis ruled last week that Home Diagnostics’ TrueTrack® and TrackEASE® blood glucose monitoring systems do not infringe U.S. Patent No. 5,366,609, owned by Roche. The lawsuit had pitted Roche, one of the leaders in the medical…
-
By Jason Derry ARIUS Research Inc. has announced that two new U.S. patents relating to its anti-cancer antibody program have issued. U.S. Patent No. 7,175,846 specifically relates to methods of treating cancer using antibodies that destroy melanoma, breast, and prostate cancer cells while ignoring normal cells. Representative independent claim 2 recites: 2. A…
-
By Donald Zuhn On March 7, 2007, INEX Pharmaceuticals Corp. and Alnylam Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Application No. 09/431,594, which covers nucleic acid-lipid compositions. According to the statement released by INEX, the allowed claims "cover[] cationic liposome compositions…
-
By Christopher P. Singer Avalon Pharmaceuticals® announced in a March 7, 2007 press release a collaboration with Merck & Co., Inc. for drug discovery, development, and commercialization of inhibitors of a target that is important in cancer development. Avalon brings its AvalonRx® screening technology platform to the collaboration and will screen a number…
Patent Docs 